[go: up one dir, main page]

Panwar et al., 2023 - Google Patents

Molecular docking of phyto-compounds against VP1 and VP2 proteins of IPNV (Infectious Pancreatic Necrosis Virus) for deriving possible therapeutic agents

Panwar et al., 2023

Document ID
13164593220133651388
Author
Panwar S
Thapliyal M
Pande A
Thapliyal A
Publication year
Publication venue
Materials Today: Proceedings

External Links

Snippet

Abstract Infectious Pancreatic Necrosis Virus (IPNV) is able to produce severe and congenital infections in fingerlings and fry salmonid fishes with high mortality up to 90%. Infected fishes that overcome IPN remain as asymptomatic carriers. Carrier fish may be the …
Continue reading at www.sciencedirect.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
    • A61K36/704—Polygonum, e.g. knotweed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Vincent et al. Molecular docking studies on the anti-viral effects of compounds from Kabasura Kudineer on SARS-CoV-2 3CLpro
Adhikari et al. Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID‐19: A review
Antonopoulou et al. Inhibition of the main protease of SARS-CoV-2 (Mpro) by repurposing/designing drug-like substances and utilizing nature’s toolbox of bioactive compounds
Mohan et al. Bioactive natural antivirals: An updated review of the available plants and isolated molecules
He et al. Herb-induced liver injury: phylogenetic relationship, structure-toxicity relationship, and herb-ingredient network analysis
Periferakis et al. Kaempferol: A review of current evidence of its antiviral potential
Alshawsh et al. Hepatoprotective effects of orthosiphon stamineus extract on thioacetamide‐induced liver cirrhosis in rats
Wu et al. Activity investigation of pinostrobin towards herpes simplex virus-1 as determined by atomic force microscopy
Dziduch et al. The current directions of searching for antiparasitic drugs
Ansari et al. Anti-inflammatory, anti-diarrheal, thrombolytic and cytotoxic activities of an ornamental medicinal plant: Persicaria orientalis
Lee et al. β‐Glucuronidase inhibitor tectorigenin isolated from the flower of Pueraria thunbergiana protects carbon tetrachloride‐induced liver injury
Cho et al. Prenylated phenolic compounds from the leaves of Sabia limoniacea and their antiviral activities against porcine epidemic diarrhea virus
Chen et al. Magnolol protects Ctenopharyngodon idella kidney cells from apoptosis induced by grass carp reovirus
Gediz Erturk et al. A multidisciplinary approach to coronavirus disease (COVID-19)
Mousavi et al. Novel Drug Design for Treatment of COVID‐19: A Systematic Review of Preclinical Studies
Santos-Ferreira et al. Current and future antiviral strategies to tackle gastrointestinal viral infections
Ibekwe et al. Plant natural products research in tuberculosis drug discovery and development: a situation report with focus on Nigerian biodiversity
Ganguly et al. In silico analysis reveals the inhibitory potential of madecassic acid against entry factors of SARS-CoV-2
Panwar et al. Molecular docking of phyto-compounds against VP1 and VP2 proteins of IPNV (Infectious Pancreatic Necrosis Virus) for deriving possible therapeutic agents
Selim et al. Antiviral activities of olive oil apigenin and taxifolin against SARS-CoV-2 RNA-dependent RNA polymerase (RdRP): in silico, pharmacokinetic, ADMET, and in-vitro approaches
Tammaro et al. Direct-acting antivirals and host-targeting approaches against enterovirus B infections: recent advances
Bharathi et al. In silico screening of potential phytocompounds from several herbs against sars-cov-2 indian delta variant b. 1.617. 2 to inhibit the spike glycoprotein trimer
Song et al. Immune responses and protective efficacy on 4-(2-methoxyphenyl)-3, 4-dihydro-2H-chromeno [4, 3-d] pyrimidine-2, 5 (1H)-dione against spring viremia of carp virus in vivo
Mohanasundaram et al. Molecular docking, dynamics simulations, ADMET, and DFT calculations: combined in silico approach to screen natural inhibitors of 3CL and PL proteases of SARS‐CoV‐2
Heleno et al. Plant extracts and SARS-CoV-2: research and applications